Arimidex Générique est utilisé pour traiter le cancer du sein chez les femmes postménopausées, incluant les femmes aux prises avec une progression de la maladie après un traitement au tamoxifène.
I-Team 10 investigation: Cost of prescription drugs - News 10NBC
News 10NBCI-Team 10 investigation: Cost of prescription drugsNews 10NBCWe looked at the breast cancer drug Arimidex and its generic -- Anastrozole.
Significant breakthrough for women with ER+HER2 - Irish Medical Times
Irish Medical TimesSignificant breakthrough for women with ER+HER2Irish Medical Times.
MDx/CDx Focus: NanoString Kicks off Second PAM50 Validation Study; MDxHealth ... - GenomeWeb
MDx/CDx Focus: NanoString Kicks off Second PAM50 Validation Study; MDxHealth .
NanoString Initiates Second Clinical Validation Study for Breast Cancer Assay - MarketWatch (press release)
NanoString Initiates Second Clinical Validation Study for Breast Cancer AssayMarketWatch (press release)The ABCSG8 study, initiated in 1996, demonstrated that compared to treatment with tamoxifen alone, sequential adjuvant treatment with tamoxifen followed by anastrozole in postmenopausal women with hormone receptor-positive early-stage breast cancer .
Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality Reduction - MarketWatch (press release)
Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality ReductionMarketWatch (press release)Drugs covered include: Abiraterone acetate (Zytiga), Afatinib (Tomtovok), Afimoxifene (TamoGel), Albumin-bound paclitaxel (Abraxane), Anastrozole (Arimidex), Apatinib, Bevacizumab (Avastin), Bosutinib, Capecitabine (Xeloda), Cediranib, .